Accelerated Cure Project, Quest Diagnostics, and National Multiple Sclerosis Society Form Research Collaboration
Study will focus on immune response to COVID-19 vaccinations of people living with multiple sclerosis.
Accelerated Cure Project for multiple sclerosis (MS), with its iConquerMS™ People-Powered Research Network initiative, is collaborating with Quest Diagnostics and the National Multiple Sclerosis Society to study immune response to COVID-19 vaccinations of people living with multiple sclerosis.
The study will employ a decentralized clinical trial model by which Quest's national network of patient service centers will enable participants to conveniently provide periodic blood specimens.
Read more about the study
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Articles
Operational Strategies That Strengthened the NIMBLE Trial DesignSeptember 16th 2025
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
